EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Insulin Resistance Exacerbates Hyperandrogenism and Hormonal Imbalance in Polycystic Ovary Syndrome: A Case-Control Study

Al-Furat Journal for Health and Medical Sciences · 15.03.2026 · 2 (1) · 265-273

DOI: 10.46649/t5vrd366 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Al-Furat Journal for Health and Medical Sciences, online erschienen am 15.03.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder that is characterized by hyperandrogenism, ovarian dysfunction, and metabolic disturbances. Insulin resistance (IR), present in 50–70% of PCOS cases, exacerbates hormonal imbalances by stimulating ovarian androgen synthesis and suppressing sex hormone-binding globulin (SHBG).

Objective

This study aimed to evaluate the role of insulin resistance in driving hyperandrogenism and hormonal dysregulation in PCOS patients compared with healthy controls.

Methods

This case-control study included 60 women diagnosed with PCOS (Rotterdam criteria) and 30 age-matched healthy controls. Participants were recruited from a fertility center, excluding smokers, those with chronic conditions, and those taking medications affecting the outcomes. Fasting blood samples collected on menstrual cycle day 2 were analyzed for glucose, insulin, LH, FSH, and testosterone. Insulin resistance was assessed via HOMA-IR.

Results

PCOS patients exhibited significantly higher BMI (p = 0.004), hirsutism (86.7% vs. 0%, p < 0.001), and menstrual irregularities (80% vs. 6.7%, p < 0.001) than controls. Metabolic parameters, including fasting glucose (104.32 ± 15.23 vs. 86.47 ± 7.08 mg/dL), insulin (14.91 ± 3.01 vs. 8.22 ± 2.47 µU/mL), and HOMA-IR (3.77 ± 1.01 vs. 1.74 ± 0.52), were elevated in PCOS (p < 0.001). Hormonal profiles showed increased LH (10.12 ± 1.84 vs. 4.21 ± 1.4 IU/mL), FSH (6.13 ± 1.48 vs. 4.23 ± 1.2 IU/mL), and testosterone (2.11 ± 0.86 vs. 0.73 ± 0.48 ng/mL) in PCOS (p < 0.001).

Conclusion

Insulin resistance is a central driver of hyperandrogenism and hormonal dysregulation in PCOS, perpetuating metabolic and reproductive dysfunctions.

Zitieren

APA

(2026). Insulin Resistance Exacerbates Hyperandrogenism and Hormonal Imbalance in Polycystic Ovary Syndrome: A Case-Control Study. Al-Furat Journal for Health and Medical Sciences, 2(1), 265-273. https://doi.org/10.46649/t5vrd366

Vancouver

Insulin Resistance Exacerbates Hyperandrogenism and Hormonal Imbalance in Polycystic Ovary Syndrome: A Case-Control Study. Al-Furat Journal for Health and Medical Sciences. 2026;2(1):265-273. doi:10.46649/t5vrd366

BibTeX
@article{euvimed2026,
  title = {Insulin Resistance Exacerbates Hyperandrogenism and Hormonal Imbalance in Polycystic Ovary Syndrome: A Case-Control Study},
  journal = {Al-Furat Journal for Health and Medical Sciences},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {265--273},
  doi = {10.46649/t5vrd366}
}
Kostenlos starten →